CIPRA.ai is the accumulation of eight years of R&D and clinical trials at UC San Diego – supported by Kaiser Permanente, UC San Diego Population Health, Altman Clinical Translational Research Institute, Samsung, Teradata and other industry leaders – which focused on using AI to precisely diagnose and treat patients with chronic conditions. The impetus for this work came from CIPRA.ai's founder Sujit Dey, after a series of self-experiments determined that sleep was the greatest contributor to his hypertension. These findings motivated Sujit to develop a data-driven, intelligent solution to untangle the complex relationships between lifestyle and chronic conditions, as he was joined by former PhD students and co-founders Jared Leitner and PoHan Chiang. Assembling a distinguished team of physicians and experts, the company was launched in July of 2022 and has expanded its AI-based platform to cover chronic hypertension and diabetes, reaching global influence through health system partners